돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 18864생성일: 2026년 10월 24일

Lithium Chloride → 1,1'-[[(Propane-1,3-diyl)dioxy]bis[(11S,11aS)-10-(2,2,2-trichloroethoxycarbonyl)-11-(tert-butyldimethylsilyloxy)-7-methoxy-2-ethynylphenyl-1,10,11,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one]]

https://huagongshe.com/ko/reaction/18864

반응식

참여 물질

역할이름HCID투입량
반응물Lithium ChlorideHCID 433294—
반응물Tributyl(2-phenylethynyl)stannaneHCID 630640—
반응물1,1'-[[(Propane-1,3-diyl)dioxy]bis[(11S,11aS)-10-(2,2,2-trichloroethoxycarbonyl)-11-(tert-butyldimethylsilyloxy)-7-methoxy-2-[[(trifluoromethyl)sulfonyl]oxy]-1,10,11,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one]]HCID 131728191—
촉매HCID 178418397HCID 178418397—
용매TetrahydrofuranHCID 8028—
생성물1,1'-[[(Propane-1,3-diyl)dioxy]bis[(11S,11aS)-10-(2,2,2-trichloroethoxycarbonyl)-11-(tert-butyldimethylsilyloxy)-7-methoxy-2-ethynylphenyl-1,10,11,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one]]HCID 13172819292.7%

반응 단계

A catalytic amount of Pd(PPh3)4 was added to a stirred mixture of triflate 13 (193 mg, 0.13 mmol), LiCl (34 mg, 0.80 mmol, 6.0 eq) and tributyl(phenylethynyl)tin (0.14 mL, 157 mg, 0.40 mmol, 3.0 eq) in dry THF (5 mL). The reaction mixture was heated at reflux for 2.5 h when TLC showed the complete consumption of the starting material. After cooling to room temperature, excess solvent was removed and the residue was dissolved in DCM (20 mL), followed by washing with 10% NH4OH (20 mL). The aqueous layer was extracted with DCM (3×20 mL), and the organic extracts were combined, washed with brine (50 mL) and dried (MgSO4). Filtration and evaporation of solvent afforded the crude product which was purified by flash column chromatography (80:20 v/v hexane/EtOAc) to afford 17 as a yellow glass (162 mg, 90%): 1H NMR (400 MHz, CDCl3) δ 7.40-7.37 (m, 4H, H15), 7.26-7.19 (m, 10H, H3, H6, H16 and H17), 6.70 (s, 2H, H9), 5.85 (d, 2H, J=8.8 Hz, H11), 5.15 (d, 2H, J=12.0 Hz, Troc CH2), 4.24-4.19 (m, 2H, OCH2CH2CH2O), 4.12-4.02 (m, 4H, Troc CH2 and OCH2CH2CH2O), 3.86-3.79 (m, 8H, OCH3×2 and H11a), 3.15 (dd, 2H, J=10.8, 16.5 Hz, H1), 2.63 (d, 2H, J=16.5 Hz, H1), 2.37-2.35 (m, 2H, OCH2CH2CH2O), 0.82 (s, 18H, TBS CH3×6), 0.22 and 0.18 (s×2, 12H, TBS CH3×4); 13C NMR (100.6 MHz, CDCl3) δ 163.8 (Cquat), 153.6 (Cquat), 150.8 (Cquat), 149.3 (Cquat), 133.3 (C3), 131.4 (C15), 128.4 (C16 and C17), 127.8 (Cquat), 125.1 (Cquat), 123.0 (Cquat), 114.0 (C6), 110.0 (C9), 104.8 (Cquat), 95.2 (Troc CCl3), 93.7 (Calkyne), 86.9 (C11), 83.6 (Calkyne), 74.8 (Troc CH2), 66.0 (OCH2CH2CH2O), 61.4 (C11a), 56.2 (OCH3), 37.8 (C1), 28.8 (OCH2CH2CH2O), 25.6 (TBS CH3), 17.8 (TBS Cquat); MS (ES), m/z (relative intensity) 1344 (M+., 8), 625 (100).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07741319B2
출처 데이터셋uspto-grants-2010_06
ORD IDord-70a15ae2f5494d6e8d04e4f7cad1a8a8
출처 메모uspto-grants-2010_06